Notably, the association among PP, tau deposition, and longitudinal cognitive decline was particularly pronounced in APOE4 carriers, suggesting that genetic susceptibility to AD may amplify the negative effects of vascular dysfunction on cognitive outcomes. The gene discussed is MAPT; the disease is Mental deterioration.